315 related articles for article (PubMed ID: 3001420)
1. Comparisons of the potential utility of LHRH agonists and antagonists for fertility control.
Vickery BH
J Steroid Biochem; 1985 Nov; 23(5B):779-91. PubMed ID: 3001420
[TBL] [Abstract][Full Text] [Related]
2. Luteinizing hormone-releasing hormone (LHRH) and its analogs for contraception in women: a review.
Thau RB
Contraception; 1984 Feb; 29(2):143-62. PubMed ID: 6426857
[TBL] [Abstract][Full Text] [Related]
3. Luteinizing hormone releasing hormone analogues for contraception.
Nillius SJ
Clin Obstet Gynaecol; 1984 Dec; 11(3):551-72. PubMed ID: 6391776
[TBL] [Abstract][Full Text] [Related]
4. Reversible inhibition of testicular function by a gonadotropin hormone-releasing hormone antagonist in monkeys (Macaca fascicularis).
Weinbauer GF; Surmann FJ; Akhtar FB; Shah GV; Vickery BH; Nieschlag E
Fertil Steril; 1984 Dec; 42(6):906-14. PubMed ID: 6389185
[TBL] [Abstract][Full Text] [Related]
5. Anti-LHRH and anti-pituitary gonadotropin vaccines: their development and clinical applications.
Thau R
Scand J Immunol Suppl; 1992; 11():127-30. PubMed ID: 1514027
[TBL] [Abstract][Full Text] [Related]
6. Suppression of pituitary-gonadal function by a potent new luteinizing hormone-releasing hormone antagonist in normal men.
Pavlou SN; Wakefield GB; Island DP; Hoffman PG; LePage ME; Chan RL; Nerenberg CA; Kovacs WJ
J Clin Endocrinol Metab; 1987 May; 64(5):931-6. PubMed ID: 3104388
[TBL] [Abstract][Full Text] [Related]
7. Endocrine approaches to male fertility control.
Knuth UA; Nieschlag E
Baillieres Clin Endocrinol Metab; 1987 Feb; 1(1):113-31. PubMed ID: 3297020
[TBL] [Abstract][Full Text] [Related]
8. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
[TBL] [Abstract][Full Text] [Related]
9. Current status of antagonistic analogs of LH-RH as a contraceptive method in the female.
Schally AV
Res Front Fertil Regul; 1983 Jul; 2(5):1-16. PubMed ID: 12179624
[TBL] [Abstract][Full Text] [Related]
10. Contraception with an LHRH agonist: effect on gonadotrophin and steroid secretion patterns.
Kuhl H; Jung C; Taubert HD
Clin Endocrinol (Oxf); 1984 Aug; 21(2):179-88. PubMed ID: 6432376
[TBL] [Abstract][Full Text] [Related]
11. Contraception with LHRH agonists, a new physiological approach.
Labrie F; Séguin C; Bélanger A; Lefebvre FA; Massicotte J; Kelly PA; Pelletier G; Reeves JJ; Lemay A; Cusan L; Raynaud JP
Reproduccion; 1981; 5(4):229-41. PubMed ID: 6274723
[TBL] [Abstract][Full Text] [Related]
12. Ovulation inhibition with nafarelin acetate nasal administration for six months.
Brenner PF; Shoupe D; Mishell DR
Contraception; 1985 Dec; 32(6):531-51. PubMed ID: 2936564
[TBL] [Abstract][Full Text] [Related]
13. Potent pituitary-gonadal axis suppression and extremely low anaphylactoid activity of a new gonadotropin releasing hormone (GnRH) receptor antagonist "azaline B".
Campen CA; Lai MT; Kraft P; Kirchner T; Phillips A; Hahn DW; Rivier J
Biochem Pharmacol; 1995 May; 49(9):1313-21. PubMed ID: 7763313
[TBL] [Abstract][Full Text] [Related]
14. Acute and chronic effects of a gonadotrophin-releasing hormone antagonist on pituitary and testicular function in monkeys.
Bint Akhtar F; Weinbauer GF; Nieschlag E
J Endocrinol; 1985 Mar; 104(3):345-54. PubMed ID: 3882872
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of ovulation: comparison between the mechanism of action of steroids and GnRH analogues.
Bouchard P; Wolf JP; Hajri S
Hum Reprod; 1988 May; 3(4):503-6. PubMed ID: 3292571
[TBL] [Abstract][Full Text] [Related]
16. Clinical applications of LHRH and its analogues.
Sandow J
Clin Endocrinol (Oxf); 1983 Jun; 18(6):571-92. PubMed ID: 6136347
[TBL] [Abstract][Full Text] [Related]
17. LH-RH agonists and antagonists.
Schally AV; Coy DH; Arimura A
Int J Gynaecol Obstet; 1980; 18(5):318-24. PubMed ID: 6110575
[TBL] [Abstract][Full Text] [Related]
18. Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration.
Dubourdieu S; Charbonnel B; Massai MR; Marraoui J; Spitz I; Bouchard P
Fertil Steril; 1991 Sep; 56(3):440-5. PubMed ID: 1894021
[TBL] [Abstract][Full Text] [Related]
19. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
Fraser HM; Nestor JJ; Vickery BH
Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
[TBL] [Abstract][Full Text] [Related]
20. Suppression of plasma gonadotropins and testosterone in adult male monkeys (Macaca fascicularis) by a potent inhibitory analog of gonadotropin-releasing hormone.
Adams LA; Bremner WJ; Nestor JJ; Vickery BH; Steiner RA
J Clin Endocrinol Metab; 1986 Jan; 62(1):58-63. PubMed ID: 3079603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
